FDA strategic Roadmap for 2018 and beyond - in silico virtual patients

Good news: The new FDA strategic Roadmap for 2018 focuses on computer modelling and simulation;

specifically on in silico virtual patients. This is right up our alley and great for future medicine 👁️ 

For more information on computer modelling and in silico virtual patients , please consult our Virtual Clinical Trials page.

To read the article, please visit VPH-Institute's newspage, where you can also find a link to the FDA's  Roadmap